Morgan Stanley Teva Pharmaceutical Industries LTD Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Morgan Stanley holds 13,555,893 shares of TEVA stock, worth $303 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

13,555,893

Previous 13,139,202 3.17%

Holding current value

$303 Million

Previous $214 Million 14.41%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $6.59 Million - $7.9 Million	416,691 Added 3.17%	13,555,893 $244 Million
Q2 2024 Oct 17, 2024	BUY	$12.78 - $17.4 $98.6 Million - $134 Million	7,713,582 Added 142.17%	13,139,202 $214 Million
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $98.6 Million - $134 Million	7,713,582 Added 142.17%	13,139,202 $214 Million
Q1 2024 Oct 17, 2024	SELL	$10.67 - $14.43 $82.3 Million - $111 Million	-7,713,582 Reduced 58.71%	5,425,620 $76.6 Million
Q1 2024 Aug 16, 2024	SELL	$10.67 - $14.43 $29.9 Million - $40.4 Million	-2,799,460 Reduced 34.04%	5,425,620 $76.6 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $29.9 Million - $40.4 Million	-2,799,460 Reduced 34.04%	5,425,620 $76.6 Million
Q4 2023 Aug 16, 2024	SELL	$8.12 - $10.63 $39.9 Million - $52.2 Million	-4,914,122 Reduced 37.4%	8,225,080 $85.9 Million
Q4 2023 Feb 13, 2024	BUY	$8.12 - $10.63 $19.6 Million - $25.7 Million	2,416,602 Added 41.6%	8,225,080 $85.9 Million
Q3 2023 Nov 15, 2023	SELL	$7.48 - $10.7 $8.54 Million - $12.2 Million	-1,141,312 Reduced 16.42%	5,808,478 $59.2 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $15 Million - $19.7 Million	2,080,202 Added 42.72%	6,949,790 $52.3 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $11.9 Million - $16.2 Million	-1,424,405 Reduced 22.63%	4,869,588 $43.1 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $3.7 Million - $4.41 Million	465,489 Added 7.99%	6,293,993 $57.4 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $290,994 - $506,907	-42,419 Reduced 0.72%	5,828,504 $47 Million
Q2 2022 Oct 27, 2022	BUY	$7.38 - $10.4 $14.7 Million - $20.7 Million	1,993,556 Added 51.42%	5,870,923 $44.1 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $14.7 Million - $20.7 Million	1,993,556 Added 51.42%	5,870,923 $44.1 Million
Q1 2022 Oct 27, 2022	SELL	$7.33 - $9.39 $14.6 Million - $18.7 Million	-1,993,556 Reduced 33.96%	3,877,367 $36.4 Million
Q1 2022 May 13, 2022	BUY	$7.33 - $9.39 $2.16 Million - $2.77 Million	295,320 Added 8.24%	3,877,367 $36.4 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $7.34 Million - $9.46 Million	928,791 Added 35.01%	3,582,047 $28.7 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $22.2 Million - $27 Million	2,653,256 New	2,653,256 $25.8 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account